|
Comparison
|
Studies
|
RR (95%CI)
|
PA value
|
I2
|
PH value
|
Model
|
|---|
|
Overall
| |
7
|
1.34(1.20, 1.50)
|
< 0.001
|
0.0
|
0.544
|
F
|
|
Subgroup
| |
|
Country
|
Asian
|
7
|
1.34(1.20, 1.50)
|
< 0.001
|
0.0
|
0.544
|
F
|
|
Non-Asian
|
0
|
–
|
–
|
–
|
–
|
–
|
|
Sample size
|
< 200
|
3
|
1.30(1.05, 1.61)
|
0.017
|
0.0
|
0.707
|
F
|
|
> 200
|
4
|
1.36(1.19, 1.55)
|
< 0.001
|
27.3
|
0.248
|
F
|
|
Cut-off
|
< 600
|
4
|
1.18(0.97, 1.43)
|
0.094
|
0.0
|
0.393
|
F
|
|
> 600
|
3
|
1.46(1.27, 1.67)
|
< 0.001
|
0.0
|
0.972
|
F
|
|
Cancer type
|
Cervical cancer
|
2
|
1.04(0.74, 1.48)
|
0.807
|
0.0
|
0.338
|
F
|
|
Ovarian cancer
|
2
|
1.47(1.23, 1.75)
|
< 0.001
|
0.0
|
0.881
|
F
|
|
Breast cancer
|
3
|
1.35(1.15, 1.59)
|
< 0.001
|
0.0
|
0.617
|
F
|
|
TNBC
|
1
|
1.43(1.13, 1.80)
|
0.0003
|
–
|
–
|
–
|
|
Other BC type
|
2
|
1.29(1.03, 1.60)
|
0.026
|
0.0
|
0.404
|
F
|
|
Follow-up
|
< 48 m
|
5
|
1.31(1.13, 1.52)
|
< 0.001
|
16.4
|
0.310
|
F
|
|
> 48 m
|
2
|
1.41(1.19, 1.66)
|
< 0.001
|
0.0
|
0.822
|
F
|
- TNBC triple-negative breast cancer, RR relative risk, CI confidence interval, m month, F fixed-effects, PAP value for association, PHP value for heterogeneity
